[1]
Yegodayev, K.M. and Elkabets, M. 2025. Development of a AXL/PD-1 BiCE as novel immunotherapy agent . South East European Journal of Immunology. 8, CITIM (Mar. 2025), 034. DOI:https://doi.org/10.3889/seejim.2025.6095.